Wyden’s Pharma Probe Could Build Case For Int’l Tax Reforms

Senate Finance Committee Chairman Ron Wyden’s investigation into the tax planning of major U.S. pharmaceutical companies could help fuel an effort to revamp U.S. international tax laws next year when Congress addresses expiring provisions of the Tax Cuts and Jobs Act.